Ibrutinib-Venetoclax Combination Found Effective Against Mantle Cell Lymphoma - report from ASH2023

from Medical Digest & Congress Report · host Medical Congress News

Professor Michael Wang explains their findings that combining ibrutinib and venetoclax improves progression-free survival and remission rates in patients with mantle cell lymphoma. Video: https://medicaldigest.org/scientific-contents/interview:ibrutinib-venetoclax-combination-found-effective-against-mantle-cell-lymphoma

Episode metadata supplied by the publisher feed · Published Dec 21, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

Ibrutinib-Venetoclax Combination Found Effective Against Mantle Cell Lymphoma - report from ASH2023

0:00 5:15

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical Digest & Congress Report?

This episode is 5 minutes long.

When was this Medical Digest & Congress Report episode published?

This episode was published on December 21, 2023.

Can I download this Medical Digest & Congress Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!